IBD Evidence

Symptomau

Byw gyda IBD: blinder, poen a'r rhannau nad ydynt yn mesur

Mae adferiad ar bapur a phrofiad adferiad yn bethau gwahanol, a'r bwlch yw lle mae'r rhan fwyaf o'r baich yn byw.

Diweddarwyd 3 min darllen 40 dyfyniadau Cryfder tystiolaeth 3/5

Golygfa o'r stryd o adeilad fferyllfa'r gorsaf yn Bautzen, yr Almaen
Fiver, der Hellseher · CC BY-SA 4.0 · Wikimedia Commons

Blinder

Mae blinder ymhlith y symptomau a adroddir yn aml mewn IBD ac ymhlith y rhai lleiaf a thrinwyd. Mae'n parhau mewn rhan fawr o bobl sydd â'u llid wedi'i reoli, sy'n golygu nad yw'n unig yn farc o weithgaredd clefyd.

Mae'r cyfranwyr yn cynnwys anemia (mae diffyg haearn yn gyffredin iawn ac yn gellir ei gywiro), torri cwsg, effeithiau meddyginiaeth, llid cronig, a'r baich seicolegol o salwch annisgwyl. Mae'r rhai y gellir eu cywiro yn werth eu dilyn yn benodol, oherwydd ni fydd neb yn eu codi ar eich cyfer mewn apwyntiad pymtheg munud sy'n canolbwyntio ar galprotectin.

Baich blinder mewn IBD

Iechyd meddwl

Mae cyfraddau pryder a chlefyd meddwl mewn IBD yn llawer uwch na'r cyfraddau cefndir. Mae'r esboniad amlwg — byw gyda salwch annisgwyl, stigmatized, sy'n achosi anwybodaeth weithiau yn achosi pryder — yn wir ac yn debyg nad yw'n y stori gyfan, gan y llwybrau llidiog a chroen-yng-ngheg a drafodwyd ar ein safle tystiolaeth coluddyn-yng-ngheg.

Yr hyn sy'n bwysig yn ymarferol yw bod hyn yn gellir ei thrin ac yn aml yn cael ei gollwng. Mae cymorth seicolegol yn rhan o ofal IBD yn y canllawiau Ewropeaidd ac yn cael ei ddarparu'n anghyfartal.

Y baich ymarferol

  • Pryder am fynediad i'r toiled, sy'n cyfyngu ar deithio, gwaith a bywyd cymdeithasol yn fwy nag y mae clinigwyr fel arfer yn gwerthfawrogi.
  • Anrhagweladwyedd. Mae cynllunio'n anodd pan gall fflêr ddod heb rybudd.
  • Rheoli deiet. Ysgogiadau unigol, dim rhestr ddilysedig, a llawer o gyngor gwrthdaro — gweler deiet.
  • Cyflogaeth. Mae blinder a phryder yn rhyngweithio'n wael â phatrwm gwaith caled.
  • Teithio. Storio meddyginiaeth, diogelwch bwyd a mynediad — wedi'u cwmpasu ar ein safle iechyd teithio.

Epidemioleg

Mae digwyddiad IBD yn uchel ac yn sefydlog yn Ewrop a Gogledd America ac yn cynyddu'n sydyn mewn gwledydd newydd ddiwydiannol. Mae'r patrwm daearyddol hwn yn un o'r dadleuon cryfaf dros gydran amgylcheddol — mae deiet, hylendid, gwrthfiotigau a'r microbiome i gyd yn gystadleuwyr, ac nid yw unrhyw un wedi'i sefydlu.

Cwestiynau cyffredin

Pam rwy'n flinedig iawn os ydw i mewn remisiwn?
Mae blinder yn aml yn parhau y tu hwnt i reolaeth lidiol. Gwiriwch ferritin a B12 yn gyntaf; maent yn gyffredin, yn gywiradwy ac yn aml yn cael eu colli.
Ai straen sy'n achosi fy fflachiadau?
Mae'n bosibl bod straen yn dylanwadu ar symptomau, ond mae'r dystiolaeth ei fod yn achosi llid yn wannach na'r model gwerin. Nid eich bai chi ydyw.
A fydd angen llawdriniaeth arna i?
Mae lleiafrif sylweddol yn gwneud hynny, ac mae'r gyfran wedi gostwng wrth i therapi effeithiol gyrraedd yn gynharach — gweler triniaeth.
A allaf i deithio?
Gallwch, gyda chynllunio o amgylch meddyginiaeth, yswiriant a diogelwch bwyd.
Mynediad fferyllfa ar y llawr gwaelod ar Teltower Damm yn Berlin-Zehlendorf, yr Almaen
Singlespeedfahrer · CC0 · Wikimedia Commons

Darllen cysylltiedig

Y dystiolaeth y tu ôl i'r dudalen hon Bar wedi'i stackio sy'n dangos cyfansoddiad y 20 cyhoeddiad a grybwyllir ar y dudalen hon yn ôl math astudiaeth. 14352meta-analysis (14)randomised trial (3)review (5)other (2)
24 cyhoeddiadau, 2015–2025. Mae hynny'n gymysgedd sy'n cynnwys y ddau dreial a synthese, sy'n sefyllfa lle mae honiad am achos yn rhesymol. Ffynhonnell: rhestr dyfynnu'r dudalen hon ei hun, isod.

Cyfeiriadau

Mae pob dyfyniad isod yn cysylltu â'r cofrestr adolygedig cyfoes gwreiddiol ar PubMed neu trwy DOI. Nid yw dim yma yn gymhwysedd ar gyfer cyngor meddygol.

  1. Evaluating the causal connections between sleep duration and disease prevalence: A comprehensive systematic review and meta-analysis of Mendelian randomization studies Wang Z, Yao L, Tu M · Medicine · 2026 · Meta-analysis DOIPubMed 41517697Full text
  2. Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization Assa A, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40528309
  3. Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation Wine E, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40677018Full text
  4. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease Felipez LM, Ali S, de Zoeten EF, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40692184Full text
  5. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns Steinmann M, Lampe D, Grosser J, et al. · Infection · 2024 · Meta-analysis DOIPubMed 38236326Full text
  6. Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes Zheng T, Roda G, Zabana Y, et al. · Journal of Crohn's & colitis · 2024 · Meta-analysis DOIPubMed 37768647
  7. Acute severe ulcerative colitis trials: the past, the present and the future Honap S, Jairath V, Sands BE, et al. · Gut · 2024 · Systematic review DOIPubMed 38834296Full text
  8. Vitamin D for the treatment of inflammatory bowel disease Wallace C, Gordon M, Sinopoulou V, et al. · The Cochrane database of systematic reviews · 2023 · Systematic review DOIPubMed 37781953Full text
  9. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses Buie MJ, Quan J, Windsor JW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023 · Meta-analysis DOIPubMed 35863682
  10. Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease Valvano M, Capannolo A, Cesaro N, et al. · Nutrients · 2023 · Systematic review DOIPubMed 37686856Full text
  11. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review Kuenzig ME, Fung SG, Marderfeld L, et al. · Gastroenterology · 2022 · Systematic review DOIPubMed 34995526
  12. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis Barberio B, Zamani M, Black CJ, et al. · The lancet. Gastroenterology & hepatology · 2021 · Meta-analysis DOIPubMed 33721557
  13. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Turner D, Ricciuto A, Lewis A, et al. · Gastroenterology · 2021 · Systematic review DOIPubMed 33359090
  14. ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE, Pimentel M, Brenner DM, et al. · The American journal of gastroenterology · 2021 · Clinical guideline DOIPubMed 33315591
  15. Pediatric Psoriasis Comorbidities Kittler NW, Cordoro KM · Skin therapy letter · 2020 · Clinical guideline PubMed 33196156
  16. Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review Helsel BC, Williams JE, Lawson K, et al. · Digestive diseases and sciences · 2018 · Systematic review DOIPubMed 29663265
  17. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, et al. · Gastroenterologia y hepatologia · 2018 · Systematic review DOIPubMed 29275001
  18. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I Knowles SR, Graff LA, Wilding H, et al. · Inflammatory bowel diseases · 2018 · Meta-analysis DOIPubMed 29562277
  19. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Ng SC, Shi HY, Hamidi N, et al. · Lancet (London, England) · 2017 · Systematic review DOIPubMed 29050646
  20. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Peyrin-Biroulet L, Sandborn W, Sands BE, et al. · The American journal of gastroenterology · 2015 · Systematic review DOIPubMed 26303131
  21. Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis Li F, Liu X, Wang W, et al. · European journal of gastroenterology & hepatology · 2015 · Meta-analysis DOIPubMed 25831134
  22. How IBD patients cope with IBD: a systematic review McCombie AM, Mulder RT, Gearry RB · Journal of Crohn's & colitis · 2013 · Systematic review DOIPubMed 22718016
  23. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis Lee TW, Kolber MR, Fedorak RN, et al. · Journal of Crohn's & colitis · 2012 · Meta-analysis DOIPubMed 22405161
  24. Health-related quality of life in youth with chronic gastrointestinal disease following a biofeedback enhanced cognitive behavioral therapy intervention: A randomized controlled trial Younginer ST, Westbrook A, Buzenski J, et al. · Journal of pediatric gastroenterology and nutrition · 2026 · Randomised controlled trial DOIPubMed 41486461Full text
  25. Feasibility, Acceptability, and Preliminary Effects of a Nurse-Delivered Self-Management Program for Individuals with Inflammatory Bowel Disease: A Pilot Randomized Controlled Trial Kamp K, Yoo L, Kale T, et al. · Digestive diseases and sciences · 2026 · Randomised controlled trial DOIPubMed 42470576Full text
  26. Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial Roukas C, Miller L, Büttner FC, et al. · BMJ open gastroenterology · 2026 · Randomised controlled trial DOIPubMed 42386349Full text
  27. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study Ferrante M, D'Haens G, Jairath V, et al. · Lancet (London, England) · 2024 · Randomised controlled trial DOIPubMed 39581202
  28. Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme Danese S, Dignass A, Matsuoka K, et al. · Journal of Crohn's & colitis · 2024 · Randomised controlled trial DOIPubMed 38869019Full text
  29. Acceptance and Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress: A Randomized Controlled Trial Naude C, Skvarc D, Maunick B, et al. · The American journal of gastroenterology · 2024 · Randomised controlled trial DOIPubMed 39162706Full text
  30. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial Truyens M, Lobatón T, Ferrante M, et al. · Gastroenterology · 2022 · Randomised controlled trial DOIPubMed 35940251
  31. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial Cox SR, Lindsay JO, Fromentin S, et al. · Gastroenterology · 2020 · Randomised controlled trial DOIPubMed 31586453
  32. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis Sands BE, Peyrin-Biroulet L, Loftus EV Jr, et al. · The New England journal of medicine · 2019 · Randomised controlled trial DOIPubMed 31553834
  33. Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies Caron B, Honap S, Peyrin-Biroulet L · Journal of Crohn's & colitis · 2024 · Review DOIPubMed 39475082Full text
  34. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life Nguyen TV, Damiani G, Orenstein LAV, et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2021 · Review DOIPubMed 32460374
  35. Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review Mahadea D, Adamczewska E, Ratajczak AE, et al. · Nutrients · 2021 · Review DOIPubMed 34836263Full text
  36. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Elmets CA, Leonardi CL, Davis DMR, et al. · Journal of the American Academy of Dermatology · 2019 · Review DOIPubMed 30772097
  37. Fatigue in inflammatory bowel disease Grimstad T, Norheim KB · Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke · 2016 · Review DOIPubMed 27830906
  38. Global evolution of inflammatory bowel disease across epidemiologic stages Hracs L, Windsor JW, Gorospe J, et al. · Nature · 2025 · Journal article DOIPubMed 40307548Full text
  39. Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease Parigi TL, Massimino L, Carini A, et al. · Journal of Crohn's & colitis · 2025 · Journal article DOIPubMed 39269323
  40. Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study Zhang J, Liu C, An P, et al. · United European gastroenterology journal · 2024 · Journal article DOIPubMed 38315582Full text

Cafodd y dudalen hon ei thrawsgrifiad yn awtomatig o Saesneg. Mae'r dyfyniadau a'r rhifau heb newid. Darllenwch y gwreiddiol Saesneg os yw unrhyw beth yn darllen yn rhy ddieithr. Darllenwch y gwreiddiol Saesneg